CIK: 0001281446 · Show all filings
Period: Q2 2023 (← Previous) (Next →)
Filing Date: Aug 14, 2023
Total Value ($000): $510,830 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ALPINE IMMUNE SCIENCES INC | 3,363,688 | $34,579 | 6.8% | $7.41 | — | COM | 02083G100 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 677,426 | $31,250 | 6.1% | $41.10 | +12.9% | COM | 90400D108 |
| PCVX | VAXCYTE INC | 589,211 | $29,425 | 5.8% | $26.90 | +76.2% | COM | 92243G108 |
| PLRX | PLIANT THERAPEUTICS INC | 1,550,184 | $28,089 | 5.5% | $17.73 | +33.5% | COM | 729139105 |
| — | RAPT THERAPEUTICS INC | 1,465,151 | $27,398 | 5.4% | $20.58 | — | COM | 75382E109 |
| — | POINT BIOPHARMA GLOBAL INC | 3,000,000 | $27,180 | 5.3% | $7.55 | — | COM | 730541109 |
| ZURA | ZURA BIO LTD | 3,295,000 | $27,019 | 5.3% | $8.03 | 0.0% | CLASS A ORD SHS | G9TY5A101 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 968,795 | $20,897 | 4.1% | $33.41 | -19.2% | COM | 03237H101 |
| XENE | XENON PHARMACEUTICALS INC | 530,000 | $20,405 | 4.0% | $22.27 | +78.5% | COM | 98420N105 |
| ACRS | ACLARIS THERAPEUTICS INC | 1,941,581 | $20,134 | 3.9% | $12.61 | -28.2% | COM | 00461U105 |
| CYTK | CYTOKINETICS INC | 600,000 | $19,572 | 3.8% | $40.16 | -7.9% | COM NEW | 23282W605 |
| ANAB | ANAPTYSBIO INC | 894,333 | $18,191 | 3.6% | $23.96 | -15.4% | COM | 032724106 |
| IMCR | IMMUNOCORE HLDGS PLC | 297,082 | $17,813 | 3.5% | $50.92 | — | ADS | 45258D105 |
| EOLS | EVOLUS INC | 2,434,048 | $17,696 | 3.5% | $8.90 | -3.1% | COM | 30052C107 |
| — | AEROVATE THERAPEUTICS INC | 932,158 | $15,987 | 3.1% | $23.31 | — | COM | 008064107 |
| SRPT | SAREPTA THERAPEUTICS INC | 123,600 | $14,155 | 2.8% | $128.81 | 0.0% | COM | 803607100 |
| ALKS | ALKERMES PLC | 411,453 | $12,878 | 2.5% | $30.28 | 0.0% | SHS | G01767105 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 772,000 | $12,730 | 2.5% | $18.94 | -4.7% | COM | 76243J105 |
| — | OPTINOSE INC | 8,839,939 | $10,873 | 2.1% | $1.78 | — | COM | 68404V100 |
| VKTX | VIKING THERAPEUTICS INC | 598,550 | $9,702 | 1.9% | $4.46 | +369.3% | COM | 92686J106 |
| MLYS | MINERALYS THERAPEUTICS INC | 546,059 | $9,310 | 1.8% | $16.83 | -11.2% | COM | 603170101 |
| FOLD | AMICUS THERAPEUTICS INC | 701,392 | $8,809 | 1.7% | $12.12 | -2.1% | COM | 03152W109 |
| — | GRACELL BIOTECHNOLOGIES INC | 2,268,057 | $8,641 | 1.7% | $2.26 | — | SPONSORED ADS | 38406L103 |
| APLS | APELLIS PHARMACEUTICALS INC | 94,700 | $8,627 | 1.7% | — | — | Put | 03753U106 |
| — | RENEO PHARMACEUTICALS INC | 1,083,317 | $7,107 | 1.4% | $6.50 | — | COM | 75974E103 |
| — | INTERCEPT PHARMACEUTICALS IN | 601,322 | $6,651 | 1.3% | $11.06 | — | COM | 45845P108 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 350,000 | $6,325 | 1.2% | $18.41 | 0.0% | COM | 35104E100 |
| — | GENERATION BIO CO | 1,022,537 | $5,624 | 1.1% | $5.04 | — | COM | 37148K100 |
| HRTX | HERON THERAPEUTICS INC | 4,737,368 | $5,495 | 1.1% | $3.84 | -53.5% | COM | 427746102 |
| ABOS | ACUMEN PHARMACEUTICALS INC | 1,051,267 | $5,057 | 1.0% | $4.79 | -0.0% | COM | 00509G209 |
| — | IGM BIOSCIENCES INC | 500,000 | $4,615 | 0.9% | $9.23 | — | COM | 449585108 |
| — | SERES THERAPEUTICS INC | 938,067 | $4,493 | 0.9% | $4.79 | — | COM | 81750R102 |
| — | PRECISION BIOSCIENCES INC | 7,469,736 | $3,929 | 0.8% | $1.10 | — | COM | 74019P108 |
| SLDB | SOLID BIOSCIENCES INC | 584,458 | $3,063 | 0.6% | $5.77 | -2.4% | COM NEW | 83422E204 |
| ACRS | ACLARIS THERAPEUTICS INC | 255,000 | $2,644 | 0.5% | $12.61 | -28.2% | Put | 00461U105 |
| — | TALARIS THERAPEUTICS INC | 666,033 | $2,025 | 0.4% | $3.04 | — | COM | 87410C104 |
| ACLX | ARCELLX INC | 37,500 | $1,186 | 0.2% | $30.34 | +26.0% | COMMON STOCK | 03940C100 |
| TVTX | TRAVERE THERAPEUTICS INC | 60,000 | $922 | 0.2% | $23.16 | -21.5% | COM | 89422G107 |
| — | MERSANA THERAPEUTICS INC | 70,000 | $230 | 0.0% | — | — | Call | 59045L106 |
| XENE | XENON PHARMACEUTICALS INC | 2,700 | $104 | 0.0% | $22.27 | +78.5% | Put | 98420N105 |